Zafgen
10/28/2015 / By Vicki Batts
22-year old patient loses life in drug trials for weight loss
A 22-year old patient died recently during late stage trials for an obesity drug. Zafgen Inc. says that the federal Food and Drug Administration (FDA) has put a partial hold on the development of their treatment, beloranib. It’s nice to see the FDA doing something right. The company largely focuses on drugs for the treatment of […]
1 of 1

Popular Posts

Medicine.News is a fact-based public education website published by Medicine News Features, LLC.

All content copyright © 2018 by Medicine News Features, LLC.

Contact Us with Tips or Corrections

All trademarks, registered trademarks and servicemarks mentioned on this site are the property of their respective owners.